BRTX vs RUN · rev $401.0K vs P/E 6.0, rev $2.04B
BioRestorative Therapies Inc (BRTX) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
BRTX currently screens at market cap $10.2M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the BRTX and RUN stock pages for the full models.
Not investment advice.